Koyfin Home > Directory > Health Care > ANI Pharma Inc > EV / EBITDA (ltm)

ANI Pharma Inc EV / EBITDA (ltm) Chart (ANIP)

ANI Pharma Inc annual/quarterly EV / EBITDA (ltm) from 2014 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • ANI Pharma Inc EV / EBITDA (ltm) for the quarter ending September 09, 2020 was 15.26 a -2.91% decrease of -0.44 year over year
  • ANI Pharma Inc EV / EBITDA (ltm) for the last 12 months ending September 09, 2020 was 15.26 a -2.91% decrease of -0.44 year over year
  • ANI Pharma Inc Annual EV / EBITDA (ltm) for 2020 was 15.26 a -4.93% decrease of -0.75 from 2019
  • ANI Pharma Inc Annual EV / EBITDA (ltm) for 2020 was 16.01 a 1.15% increase of 0.18 from 2019
  • ANI Pharma Inc Annual EV / EBITDA (ltm) for 2020 was 15.83 a 0.78% increase of 0.12 from 2019
Other Valuation Metrics:
  • ANI Pharma Inc Market Cap for the quarter ending March 03, 2018 was $678m a 19.72% increase of 134m year over year
  • ANI Pharma Inc Price / Book for the quarter ending March 03, 2018 was 3.88 a 18.50% increase of 0.72 year over year
  • ANI Pharma Inc Enterprise Value for the quarter ending March 03, 2018 was $849m a 19.14% increase of 162m year over year
View Chart On Koyfin

Quarterly ANIP EV / EBITDA (ltm) Data

09/202015.26
09/202016.01
09/202015.83
09/202015.70
09/202015.30
09/202015.32
09/202015.04
09/202015.06
09/202015.40
09/202015.53

Annual ANIP EV / EBITDA (ltm) Data

202015.26
202016.01
202015.83
202015.70
202015.30
202015.32
202015.04
202015.06
202015.40
202015.53